Scarica l'app Stockscreener
80.14
1.12%
-0.91
Dopo l'orario di chiusura:
80.14
Precedente Chiudi:
$81.05
Aprire:
$80.56
Volume 24 ore:
505.75K
Relative Volume:
0.68
Capitalizzazione di mercato:
$4.40B
Reddito:
$1.43B
Utile/perdita netta:
$107.13M
Rapporto P/E:
41.37
EPS:
1.9372
Flusso di cassa netto:
$161.04M
1 W Prestazione:
+2.49%
1M Prestazione:
-2.54%
6M Prestazione:
+21.96%
1 anno Prestazione:
+89.95%
Intervallo 1D:
$79.29
$81.78
Intervallo di 1 settimana:
$78.31
$82.70
Portata 52W:
$41.02
$85.27
Livanova Plc Stock (LIVN) Company Profile
Nome
Livanova Plc
Settore
Industria
Telefono
4402033250662
Indirizzo
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
80.14 | 4.43B | 1.43B | 107.13M | 161.04M | 1.9372 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-19 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | Downgrade | Goldman | Buy → Neutral |
| 2025-05-20 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | Iniziato | Goldman | Buy |
| 2024-09-17 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Reiterato | Needham | Buy |
| 2024-02-20 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-09-06 | Iniziato | HSBC Securities | Hold |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-04-14 | Iniziato | Mizuho | Neutral |
| 2022-12-21 | Iniziato | Barclays | Equal Weight |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-02-24 | Aggiornamento | UBS | Neutral → Buy |
| 2021-12-03 | Iniziato | Goldman | Buy |
| 2021-08-20 | Reiterato | Needham | Buy |
| 2021-07-20 | Aggiornamento | Needham | Hold → Buy |
| 2021-03-03 | Downgrade | Berenberg | Buy → Hold |
| 2021-01-05 | Downgrade | Needham | Buy → Hold |
| 2020-09-02 | Iniziato | Robert W. Baird | Outperform |
| 2020-06-26 | Reiterato | Needham | Buy |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-02-28 | Reiterato | Needham | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-06-08 | Iniziato | Stifel | Buy |
| 2018-05-31 | Reiterato | Needham | Buy |
| 2018-02-28 | Reiterato | Needham | Buy |
Mostra tutto
Livanova Plc Borsa (LIVN) Ultime notizie
LIVN|LivaNova PLC|Price:80.640|Chg%:+2.450 - TradingKey
LivaNova PLC (LIVN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
LivaNova PLC (LIVN) Balance Sheet - TradingKey
LivaNova (NASDAQ:LIVN): A Strong Growth Stock with a Constructive Technical Setup - ChartMill
LivaNova PLC (LIVN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
LivaNova PLC (LIVN) Institutional Confidence - TradingKey
LivaNova PLC (LIVN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LIVN|LivaNova PLC|Price:78.190|Chg%:-0.420 - TradingKey
LivaNova PLC (LIVN) Cash Flow - TradingKey
LivaNova PLC (LIVN) Income Statement - TradingKey
LivaNova PLC (LIVN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
LivaNova PLC (LIVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LivaNova PLC Revenue Breakdown – NASDAQ:LIVN - TradingView
LivaNova PLC (LIVN) Stock Forecasts - Yahoo Finance
LIVN6033156 Bond Coupon Profile — Rate & Payments - TradingView
LivaNova PLC (LIVN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
LIVN6033156 Bond Risk Profile - TradingView
LIVN6033156 Bond Profile — Key Metrics - TradingView
LivaNova PLC (LIVN) Stock forecasts - Yahoo Finance UK
LivaNova (NASDAQ:LIVN) Fits the Affordable Growth Profile with Strong Earnings and Relative Value - ChartMill
(LIVN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
LivaNova PLC at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Q1 2020 LivaNova PLC Earnings Call Transcript - GuruFocus
Q3 2025 LivaNova PLC Earnings Call Transcript - GuruFocus
Q1 2025 LivaNova PLC Earnings Call Transcript - GuruFocus
LivaNova PLC (BSP:L2IV34) Stock Price, Trades & News - GuruFocus
LivaNova PLC (BSP:L2IV34)Valuation Measures & Financial Statistics - GuruFocus
LivaNova PLC (BSP:L2IV34) Stock Earnings Transcripts - GuruFocus
BSP:L2IV34 Equity-to-Asset: 0.48 — 11% Below Median - GuruFocus
LivaNova PLC Stock Operating Data - GuruFocus
BSP:L2IV34 Dividend: Does LivaNova PLC Pay a Dividend? - GuruFocus
LivaNova PLC (BSP:L2IV34) DCF Valuation - GuruFocus
LivaNova PLC Stock Warning Signs - GuruFocus
Jette Nygaard-Andersen joins LivaNova board as a new director - MSN
LIVN Maintains by Mizuho -- Price Target Raised to $95.00 - GuruFocus
LivaNova PLC (LIVN) Shares Fall 4.7% -- GF Value Says Still Over - GuruFocus
3 Service Sector Stocks With Pricing Power Investors Should Watch - Sahm
LivaNova appoints Anne Liddy as chief legal officer - MSN
LivaNova Q1 2026 Earnings: EPS Surpasses Estimates by 7.14% Amidst Mixed Market ReactionGross Profit Margin - dars.gov.et
World Cardiopulmonary Bypass MachineMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Price to earnings forward of LivaNova Plc – SWB:LIA - TradingView
LivaNova (LIVN) Edges Higher as Shares Test Mid-Range ResistanceSafe Entry Stocks - dars.gov.et
Price to sales forward of LivaNova PLC – NASDAQ:LIVN - TradingView
LivaNova PLC balances neuromodulation growth with cardiac surgery challenges - Ad-hoc-news.de
Enterprise value to EBITDA forward of LivaNova PLC – NASDAQ:LIVN - TradingView
LivaNova PLC (LIVN) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
LivaNova PLC focuses on neuromodulation and cardiopulmonary solutions as investors track its Nasdaq- - Ad-hoc-news.de
Enterprise value to revenue forward of LivaNova PLC – NASDAQ:LIVN - TradingView
Price to sales forward of LivaNova Plc – LSX:A14156 - TradingView
Price to book forward of LivaNova PLC – NASDAQ:LIVN - TradingView
How LivaNova’s Broad Russell Index Inclusion Will Impact LivaNova (LIVN) Investors - simplywall.st
Livanova Plc Azioni (LIVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Livanova Plc Azioni (LIVN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| SCHERMERHORN TODD C | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
13,105 |
| Bianchi Francesco | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
11,270 |
| Bianchi Francesco | Director |
Jun 15 '26 |
Sale |
80.19 |
1,200 |
96,228 |
9,584 |
| PODLOGAR SUSAN M | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
6,128 |
| Barry James Christopher | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
8,404 |
| Tezel Ahmet | Chief Innovation Officer |
Jun 15 '26 |
Option Exercise |
0.00 |
2,965 |
0 |
7,122 |
| KOZY WILLIAM A | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
5,681 |
0 |
38,248 |
| Enxing Seng Stacy | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
15,793 |
| Story Brooke | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
10,274 |
| Zurbay Donald | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
2,560 |
0 |
2,560 |
1.04%
11.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):